Results 31 to 40 of about 2,380,266 (312)

Aging-Related Decline of Glutathione Peroxidase 3 and Risk of Cardiovascular Events in Patients With Atrial Fibrillation [PDF]

open access: yes, 2016
BACKGROUND: Experimental studies demonstrated that glutathione peroxidase 3 (GPx3), an antioxidant enzyme that catabolizes hydrogen peroxide, protects against thrombosis. Little is known about its role in cardiovascular disease. METHODS AND RESULTS:
Carnevale, Roberto   +6 more
core   +1 more source

Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study

open access: yesBiomedicines, 2022
In the last decades, high serum levels of lipoprotein(a) (Lp(a)) have been associated with increased cardiovascular disease (CVD) risk, in particular among individuals with smaller apolipoprotein(a) (apo(a)) isoforms than those with larger sizes. The aim
Arrigo F. G. Cicero   +8 more
doaj   +1 more source

Genetic variants of Y chromosome are associated with a protective lipid profile in black men [PDF]

open access: yes, 2008
Objective— Gender and ethnicity modulate the phenotypic expression of cardiovascular risk factors. In particular, men are at higher risk of developing cardiovascular diseases compared to women, whereas black populations of African origin display reduced ...
Alfonso Siani   +17 more
core   +1 more source

Use of human PBMC to analyse the impact of obesity on lipid metabolism and metabolic status: a proof-of-concept pilot study

open access: yesScientific Reports, 2021
Peripheral blood mononuclear cells (PBMC) are widely used as a biomarker source in nutrition/obesity studies because they reflect gene expression profiles of internal tissues.
Andrea Costa   +7 more
doaj   +1 more source

The metabolic syndrome adds utility to the prediction of mortality over its components: The Vietnam Experience Study [PDF]

open access: yes, 2009
Background\ud The metabolic syndrome increases mortality risk. However, as “non-affected” individuals may still have up to two risk factors, the utility of using three or more components to identify the syndrome, and its predictive advantage over ...
Anna C. Phillips   +24 more
core   +1 more source

Migraine, headache, and mortality in women: a cohort study [PDF]

open access: yes, 2020
Background: Migraine carries a high global burden, disproportionately affects women, and has been implicated as a risk factor for cardiovascular disease. Migraine with aura has been consistently associated with increased risk of cardiovascular mortality.
Buring, Julie Elizabeth   +3 more
core   +1 more source

Comparing the effectiveness of two cardiovascular prevention programmes for highly educated professionals in general practice : a randomised clinical trial [PDF]

open access: yes, 2013
Background: Cardiovascular disease is a major cause of mortality and morbidity and its prevalence is set to increase. While the benefits of medical and lifestyle interventions are established, the effectiveness of interventions which seek to improve the ...
Claes, Neree   +4 more
core   +2 more sources

Walks4work: Rationale and study design to investigate walking at lunchtime in the workplace setting [PDF]

open access: yes, 2012
Background: Following recruitment of a private sector company, an 8week lunchtime walking intervention was implemented to examine the effect of the intervention on modifiable cardiovascular disease risk factors, and further to see if walking environment ...
A Alwan   +69 more
core   +2 more sources

Immune cell phenotyping in low blood volumes for assessment of cardiovascular disease risk, development, and progression: a pilot study

open access: yesJournal of Translational Medicine, 2020
Background Cardiovascular disease (CVD) is the leading cause of death in the world. Given the role of immune cells in atherosclerosis development and progression, effective methods for characterizing immune cell populations are needed, particularly among
Yvonne Baumer   +16 more
doaj   +1 more source

Three arms, double-blind, non-inferiority, randomized clinical study testing the lipid-lowering effect of a novel dietary supplement containing red yeast rice and artichoke extracts compared to Armolipid Plus® and placebo

open access: yesArchives of Medical Science, 2023
Introduction There is growing interest in head-to-head comparison between different lipid-lowering nutraceuticals. The aim of our study was to test the lipid-lowering effect of dietary supplementation with low-dose monacolins from red yeast rice (2.8 mg ...
Arrigo F.G. Cicero   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy